Mondelēz appoints Haleon CEO Brian McNamara to Board of Directors

Mondelez International, Inc.

Board expanded to 11 members; McNamara appointed effective Feb 1, 2024 as independent director.
McNamara has been CEO of Haleon plc (formerly GSK Consumer Healthcare) since May 2022.
He will serve on the People & Compensation and Governance, Membership & Sustainability Committees.
McNamara receives standard non-employee director compensation per 2023 proxy statement and indemnification.
No reportable transactions between McNamara and Mondelēz under Item 404(a).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian J. McNamara

Director

MDLZ · Mondelez International, Inc.

Effective: 2024-02-01
Filed: February 2, 2024, 6:59 PM ET

On February 1, 2024, we increased the size of the Mondelēz International Board of Directors (the “Board”) from 10 to 11 members and appointed Brian J. McNamara to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian J. McNamara was appointed as Director at Mondelez International, Inc..

Action: appointed
Role: Director

Exact text from the filing

On February 1, 2024, we increased the size of the Mondelēz International Board of Directors (the “Board”) from 10 to 11 members and appointed Brian J. McNamara to the Board.

View on SEC.gov

Mondelez International, Inc. filing history →

Source: SEC EDGAR

accession 0001103982-24-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.